Shots:

• The US FDA has approved Tpoxx as an IV formulation for smallpox caused by the variola virus in adults & pediatric patients. The therapy provides an alternative option who are not able to swallow oral capsules of Tpoxx
• The approval was based on animal efficacy studies in nonhuman primates & rabbits infected with nonvariola orthopoxviruses that were adequate & well-controlled
• Tpoxx is a novel small-molecule drug that prevents the formation of secondary viral envelopes in the variola virus and other poxviruses, thereby inhibiting viral maturation. The therapy has been approved in the US, Canada & EU for smallpox & is also indicated to treat monkeypox, cowpox & complications from immunization with vaccinia in the EU

Ref: Globe Newswire | Image: Siga